Drug Safety Communications
This webpage was developed to provide the public with easy access to important drug safety information. The webpage contains the most recent Drug Safety Communications from FDA as well as links for Early Communications, Follow-Up Early Communications, Information for Healthcare Professional sheets, and Public Health Advisories issued prior to January 29th, 2010. You can also find drug specific information using the Index to Drug-Specific Information2.
Starting July 18, 2011, you can find Spanish language versions of the Drug Safety Communications on our Drug Safety Communications in Spanish3 page.
El 18 de julio de 2011, se pueden encontrar versiones en español de las Comunicaciones de Seguridad de Medicamentos en nuestra Comunicaciones de la FDA sobre la seguridad de los medicamentos en español4 de la página.
Current Drug Safety Communications
- Update on the risk for serious bleeding events with the anticoagulant Pradaxa5
- Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays6
- Ongoing safety review of Parkinson’s drug Mirapex (pramipexole) and possible risk of heart failure7